The methylation of histone H3 lysine 79 (H3K79) is an active chromatin marker and is prominant in 16 actively transcribed regions of the genome. However, demethylase of H3K79 remains unknown 17 despite intensive research. Here, we show that KDM2B (also known as FBXL10), a member of the 18 Jumonji C family of proteins and known for its histone H3K36 demethylase activity, is a di-and tri-19 methyl H3K79 demethylase. We demonstrate that KDM2B induces transcriptional repression of 20 HOXA7 and MEIS1 via occupancy of promoters and demethylation of H3K79. Furthermore, genome-21 wide analysis suggests that H3K79 methylation levels increase when KDM2B is depleted, indicating 22 that KDM2B functions as an H3K79 demethylase in vivo. Finally, stable KDM2B-knockdown cell lines 23 exhibit displacement of NAD + -dependent deacetylase SIRT1 from chromatin, with concomitant 24 increases in H3K79 methylation and H4K16 acetylation. Our findings identify KDM2B as an H3K79 25 demethylase and link its function to transcriptional repression via SIRT1-mediated chromatin silencing. 26 2A). To demonstrate the specificity toward H3K79, we assessed whether KDM2B removes the methyl 128 groups from recombinant histone H3 with methyl-lysine analogs (MLAs) which was specifically 129 methylated by chemical alkylation reaction (Jia et al., 2009; Simon et al., 2007), using formaldehyde 130 dehydrogenase (FDH) assays. FDH assay measures the production of formaldehyde, a by-product 131 derived from demethylation reaction, by monitoring the reduction of nicotinamide adenine dinucleotide 132 (NAD+) into NADH (Lizcano et al., 2000; Shi et al., 2004) . We used fluorescence-based detection 133 method and assessed demethylase activity of KDM2B. It was observed that KDM2B effectively 134 produced marked amounts of formaldehyde from MLA histone H3 containing tri-methylation on Kc79, 135 confirming that H3K79 is a substrate for demethylation catalyzed by KDM2B ( Figure 2D ). The FDH 136
Introduction 27
Chromatin structure is modulated by diverse covalent histone modifications (Cheung et al., 2000; 28 Strahl and Allis, 2000) Combinations of such modifications direct both global and specific 29 transcriptional outcomes (Berger, 2007; Lee et al., 2010) . Among these modifications, histone lysine 30 methylation is linked to both activation and repression of transcription. As in the case of most 31 epigenetic modifications, histone methylation and demethylation are dynamically regulated by histone 32 methyltransferases (HMTases) and demethylases (Martin and Zhang, 2005 ; Mosammaparast and Shi, 33 2010; Wysocka et al., 2005) . 34
Histone H3 lysine 79 methylation (H3K79me) is catalyzed by the HMTase disruptor of telomeric 35 silencing-1 (Dot1)-Like (DOT1L), which is the mammalian homolog of the yeast Dot1 (Feng et al., 36 2002; Lacoste et al., 2002; Singer et al., 1998; van Leeuwen et al., 2002) . DOT1L is considered the 37 only H3K79 HMTase in mammals. However, recent reports suggest that the nuclear SET (Su(var)3-9, 38
Enhancer-of-zeste, Trithorax) domain (NSD) family of HMTases, including response element II binding 39 protein (RE-IIBP) (also known as NSD2), has H3K79-methylating activities (Morishita et al., 2014; 40 Woo Park et al., 2015). On the basis of analyses of its crystal structure, H3K79 is a surface-exposed 41 residue and is located in close proximity to lysine 123 of histone H2B in yeast cells (Luger et al., 1997; 42 Ng et al., 2002b) . Regulation occurs by trans-crosstalk, and ubiquitylation of histone H2BK123 43 (H2BK123ub) is necessary for H3K79me formation (Briggs et al., 2002) . 44 H3K79 methylation is linked to active gene transcription (Ng et al., 2003; Okada et al., 2005; 45 Okada et al., 2006; Schubeler et al., 2004; Vakoc et al., 2006) . In addition, H2BK123ub, H3K4me, 46
H3K79me, and RNA polymerase II (Pol II) phosphorylation occurs sequentially during transcriptional 47 elongation . H3K79me plays a role in DNA repair through interaction with 48 Rad9/53BP1, and the levels of H3K79me change during the cell cycle (Feng et The Jumonji C (JmjC) domain-containing histone demethylase, KDM2B, also known as FBXL10, 54 3 preferentially demethylates both H3K36me2/3 and H3K4me3 (Frescas et al., 2007; Tsukada et al., 55 2006; Wang et al., 2011) . KDM2B also mediates the monoubiquitylation of the histone H2AK119 as a 56 component of noncanonical polycomb-repressive complex 1 (PRC1) in embryonic stem cells (ESCs) 57 (Farcas et al., 2012; Wu et al., 2013) . KDM2B enhances reprogramming of ES cells via its binding to 58 unmethylated CpG sites through the zinc finger (ZF)-CXXC motif. CpG recognition and PRC1 59 targeting by KDM2B are important for the deposition of H2AK119ub1 and for further recruitment of 60 PRC2 to a subset of CpG islands, which is an activity limited to variant PRC1 complexes (Blackledge 61 et al., 2014; He et al., 2013; Liang et al., 2012) . 62 KDM2B contributes to the development of tumors in vivo, probably via H3K36 demethylase activity. 63
Overexpression of KDM2B inhibits cellular senescence by repressing the mouse loci p16Ink4a, 64 p19Arf, and p15Ink4b, and by repressing the human loci retinoblastoma (Rb) and p53, resulting in 65 cellular immortalization (Pfau et al., 2008; Tzatsos et al., 2009 ). In addition, wild-type KDM2B but not 66 a mutant with defective demethylase activity enhances the progression of pancreatic cancer in a 67 mouse model (Tzatsos et al., 2013) . Furthermore, H3K36 demethylase activity is required for 68 leukemic transformation in a Hoxa9/Meis1-induced mouse bone marrow transplantation (BMT) model 69 (He et al., 2011) . 70
In this study, we identified KDM2B as a histone demethylase that can catalyze the removal of di-71 and tri-methyl groups from the H3K79 lysine residue. We also found that KDM2B induces SIRT1-72 mediated chromatin silencing by removing H3K79me, which leads to transcriptional repression. 73
74

Results
75
Identification of the H3K79me2 peptide-interacting proteins 76
In an attempt to identify a potential H3K79 demethylase, we hypothesized an interaction between 77
H3K79me site and a corresponding demethylase or a certain complex with H3K79 demethylase 78 activity. This hypothesis led us to perform a peptide pull-down assay using H3K79me2 peptides with 79 K562 nuclear extracts. By liquid chromatography-tandem mass spectrometry (LC-MS/MS), we 80 showed that methylated H3K79 was associated with chromobox homolog 8 (CBX8), one of the 81 4 various types of CBX proteins directing the canonical PRC1 complex as an interacting component 82 ( Figure 1A and B ). To rule out the possibility of non-specific binding, we carried out pull-down assays 83 between CBX8 and H3K79me0 peptides as negative controls, and confirmed that CBX8 interacted 84 with H3K79me2 peptides but not with H3K79me0 peptides ( Figure 1C ). PRC1, one of the polycomb 85 group (PcG) multiprotein complexes, has a diverse composition that depends on the presence or 86 absence of CBX proteins (Di Croce and Helin, 2013; Gil and O'Loghlen, 2014) . Previous studies 87 isolated nuclear proteins bound to KDM2B and identified the BCL6 co-repressor (BCOR) complex by 88 mass spectrometry (Sanchez et al., 2007) . Another studies identified the presence of the KDM2B-89 containing non-canonical PRC1-BCOR-CBX8 complex (Beguelin et al., 2016; Sanchez et al., 2007) . 90
To investigate the associations of these proteins, we performed immunoprecipitation (IP) experiments 91 and showed that KDM2B bound CBX8 ( Figure 1D ). On the basis of these results, we suggest that 92 CBX8 is associated with KDM2B in a certain complex and that KDM2B possibly functions at the 93 H3K79me site. 94
95
KDM2B demethylates H3 di-/tri-methyl-K79 in vitro and in vivo 96
In addition to being a subunit of the non-canonical PRC1 complex, KDM2B is the only known 97 demethylase involved in other types of complexes containing CBX8, including the BCOR complexes. 98 Therefore, we decided to test the H3K79 demethylation activity of KDM2B (Figure 2-figure 99 supplement 1A). Ectopic expression of FLAG-tagged full-length KDM2B in 293T cells markedly 100 reduced the levels of H3K79me3 and, to a lesser degree, reduced the levels of H3K79me2. No 101 decreases in H3K79me1 levels were observed (Figure 2A , left panel). As expected, KDM2B also 102 decreased the levels of H3K36me2. However, a mutant form with a substitution of histidine with 103 alanine in the JmjC domain catalytically deficient in H3K36 demethylase activity, KDM2B-H242A, 104 failed to demethylate H3K79me3, H3K79me2, and H3K79me1 (Figure 2A , left panel). We observed 105 that DOT1L rescued the effects of KDM2B on H3K79 but not on H3K36, which confirmed the H3K79 106 We next investigated the H3K79 demethylation at the global level by comparing methylation status 108 5 in stable KDM2B knockdown 293T cells. We used two independent shRNAs targeting different 109 regions of KDM2B: one in the coding sequence (CDS) and the other in the 3′-untranslated region 110 (UTR). We found that RNA interference (RNAi) of endogenous KDM2B led to increased H3K79me3 111 and H3K79me2 levels, but mono-methylation was not affected (Figure 2A , right panel). Furthermore, 112 immunocytochemistry showed that overexpression of KDM2B in 293T cells resulted in a loss of 113
H3K79me3, in contrast with the strong H3K79me3 staining signals observed in adjacent non-114 transfected cells ( Figure 2B ). However, overexpression of KDM2B had no detectable effect on 115
H3K79me1 levels that were determined by immunocytochemistry ( Figure 2B ). 116
We confirmed the H3K79 demethylase activity of KDM2B through in vitro assays. It was necessary 117 to decide whether the above observations derived from indirect effects of genetic manipulation or from 118 the direct enzymatic activity of KDM2B. After incubation of core histones with increasing 119 concentrations of GST-KDM2B containing the JmjC, CXXC, and plant homeodomain (PHD) domains 120 (amino acids 1-734), we observed reduced levels of H3K79me2 and of H3K79me3 ( Figure 2C , left 121 panel). We examined the effects of KDM2B on nucleosomes. Similar to the effects on core histones, 122 KDM2B demethylated both H3K79me2 and H3K79me3 of nucleosomes ( Figure 2C , right panel). We 123 concluded that KDM2B had H3K79 demethylase activity both in vitro and in vivo. We performed 124 isothermal titration calorimetry (ITC) experiments to test binding affinity of KDM2B towards tri-125 methylated H3K79 peptides. Given that H3K79me3 had a much lower dissociation constant (Kd) than 126
H3K79me0, GST-KDM2B1-734 bound to H3K79me3 with stronger affinity ( 
Structural analysis of H3K79 demethylation by KDM2B 145
To obtain insights into the mechanism of the demethylation reaction, we modeled H3K79 onto the 146 KDM2B structure, based on the H3K36-bound KDM2A structure that was previously determined 147 (Cheng et al., 2014) . Given that the location of H3K79 within the protein structure is in the loop 148 between the two alpha-helices, this region could be accessible to the active site of KDM2B with a 149 slight conformational change. Remarkably, the sequences around the K79 and K36 of histone H3 are 150 similar in their chemical properties. In accordance with the sequence alignment of residues 151 surrounding the H3K79 and H3K36 ( Figure 3A ), this modeling exercise indicated that the hydrophobic 152 residues in the H3K79 peptide (Phe78, Leu82, and Phe84) are involved in hydrophobic interactions 153 with KDM2B. This is similar to what occurs in the interactions of the H3K36 peptide with the complex 154 structure of KDM2A ( Figure 3B ). The residues (His242 and His314) for binding of iron and alpha-155 ketoglutarate (α-KG) were also conserved in the modeled structure ( Figure 3B ), indicating 156 concomitant bindings of these co-factors with the H3K79 peptide. Together, these findings indicate 157 that H3K79 is a plausible demethylation site for KDM2B. 158
We also verified the H3K79 demethylase activity of KDM2B, using core histone substrates 159 radiolabeled by DOT1L (which is responsible for methylation at K79 sites). KDM2B significantly 160 decreased the levels of H3K79-methylated histones ( Figure 3C ). In addition, since KDM2B was well in radioactivity of each histone substrate following demethylation by KDM2B ( Figure 3D ). Therefore, 166 these findings suggest that H3K79 demethylase activity of KDM2B is catalytically effective based on 167 the degrees of H3K36 and H3K4 demethylation. KDM2B was required for the repressive function of the protein, the catalytically inactive mutant 180 (H242A) and ΔCXXC mutant were tested in reporter assays using the HOXA7 promoter. A significant 181 absence of transcriptional repression was observed in assays using the ΔCXXC mutant, and partial 182 repression was observed in assays using the H242A point mutant ( Figure 4B ). To examine whether 183 the demethylation of H3K79 catalyzed by KDM2B led to downregulation of general transcription, we 184 carried out luciferase assays using simian virus 40 (SV40) and thymidine kinase (TK) promoters. Using these four known target genes, we demonstrated that H3K79 demethylation alone, without 195 H3K36 or H3K4 demethylation, was involved in KDM2B-mediated repression. We measured the 196 transcription levels of the four target genes using wild-type and K4/36R mutant histone H3. As 197 expected, these four genes showed clear downregulation in H3 K4/36R-overexpressing stable cells, 198 similar to their levels in H3 wild-type-overexpressing stable cells when KDM2B was ectopically 199 expressed ( Figure 4C ). Taken together, we established that H3K79 demethylation is indeed required 200 for KDM2B-mediated repression in addition to H3K36 and H3K4 demethylations. 201
202
KDM2B depletion regulates gene expression through genome-wide accumulation of H3K79me 203
To determine the global location of H3K79me sites under the influence of KDM2B, we performed 204
ChIP-seq in KDM2B knockdown stable 293T cells. A comparison of the two ChIP-seq data sets 205 (control shRNA (shCTL) vs. shKDM2B) using heat maps showed that, at the global human genome 206 level, H3K79me3 was enriched under the condition of KDM2B depletion ( Figure 5A ). The normalized 207 sequencing depth of ChIP-seq data revealed that, under the KDM2B knockdown condition, 208 methylation marks were considerably enriched around the centers of H3K79me3 peaks, suggesting 209 that KDM2B ablation strongly upregulated H3K79me3 ( Figure 5B ). We confirmed that marked 210 increases in H3K79me3 occupancy (at the genome-wide level) were correlated with KDM2B 211 knockdown by analyzing the mean ChIP-seq tag density of shKDM2B compared to that of a shCTL 212 ( Figure 5C ). ChIP-seq binding profiles on individual genes such as GATA4 and PDE3B clearly 213 indicated that H3K79me3 levels were upregulated in the shKDM2B stable cell line ( Figure 5D ). To 214 validate the ChIP-seq experiment, we selected a KDM2B-responsive gene, PDE3B, and performed 215 ChIP-qPCR. H3K79me3 accumulated on the PDE3B promoter when KDM2B was depleted ( Figure  216 5E). To characterize chromatin profiles near transcription start sites (TSSs) of H3K79me3-occupied 217 genes, sensitive to KDM2B depletion, we compared H3K79me3 peaks with published ChIP-seq 218 studies for KDM2B in human acute myeloid leukemia (AML) cells (van den Boom et al., 2016). We 219 noticed that alterations of H3K79me were correlated with KDM2B binding. KDM2B peaks were 220 localized at EGLN1 and CYFIP1 loci, and H3K79me3 occupancy increased at these two genes after 221 chromatin that contains hypomethylated H3K79, and they block H3K79me (Ng et al., 2003) . As a 247 member of the sirtuin family of proteins, SIRT1 is the human homolog of the yeast Sir2 protein, and 248 mediates deacetylation of histones H3, H4, and H1 (Vaquero et al., 2004) . To delineate the 249 relationship between H3K79 demethylation and SIR protein-mediated transcriptional repression, we 250 tested whether KDM2B induced the recruitment of SIRT1 to the target gene promoters. We measured 251 the levels of SIRT1 and H4K16ac on the HOXA7, MEIS1, ALX1, and GATA4 promoters by ChIP-252 qPCR analysis in KDM2B knockdown stable cell lines. We found that depletion of KDM2B increased 253
H3K79me3 levels ( Figure 5G ), leading to disruption of chromatin binding of SIRT1 and to increase in 254
H4K16ac levels ( Figure 6A ). Enrichment of H4K16ac under KDM2B ablation provides evidence for a 255 correlation between H3K79me and H4K16ac in transcriptional upregulation. A recent study on the 256 functional interplay between DOT1L and bromodomain-containing protein 4 (BRD4) reported that 257
H3K79me, by itself, was not necessary for transcriptional activation, and that H4 acetylation was 258 required for the actual regulatory effects to occur as downstream events (Gilan et al., 2016) . To 259 evaluate a model of SIRT1 recruitment, we overexpressed KDM2B in the KDM2B knockdown stable 260 cell line. As expected, H3K79 hypomethylation-facilitated SIRT1 binding was rescued by ectopic 261 KDM2B (Figure 6-figure supplement 1). We tested whether KDM2B interacted with SIRT1. IP analysis 262 in 293T cells overexpressing KDM2B and SIRT1 showed that KDM2B bound SIRT1, and the 263 interaction between endogenous SIRT1 and KDM2B was also detected ( Figures 6B and C) . SIRT1 264 has been shown to inhibit chromatin binding of DOT1L by H3K9me2 accumulation and chromatin 265 compaction via SUV39H1 localization (Chen et al., 2015) . To examine whether the decreases in 266
H3K79me levels mediated by KDM2B were due to its association with SIRT1 and concomitant failure 267 of DOT1L recruitment, we performed IP assay in wild-type and catalytic mutant of KDM2B 268 overexpressed cells, and confirmed that KDM2B-H242A also bound SIRT1 ( Figure 6-figure  269 supplement 2). Given that KDM2B-H242A did not alter H3K79me3 levels, as shown in Figure 2A and 270 Figure 6D ). This is consistent with the results of a previous study that described the fact that H3K79me is evolutionarily conserved in a wide variety of eukaryotes is a strong indication of 285 its fundamental role in the regulation of chromatin structure (Mersfelder and Parthun, 2006) . Although 286 extensive studies have been conducted to characterize the role of H3K79me in transcriptional 287 regulation and its physiological outcome, the identity of the H3K79 demethylase has been uncertain. 288
In this work, we identified KDM2B as a histone H3K79me2/3 demethylase. By pull-down assay 289 followed by mass spectrometry analyses, we identified H3K79me2-interacting proteins, including 290 Our current study reveals that KDM2B is an H3K79me2/3 demethylase and acts as a 320 transcriptional co-repressor. By ChIP-seq and ChIP-qPCR analyses, we determined that KDM2B led 321 to loss of H3K79me on target genes. Interestingly, previous study found that knockout of DOT1L 322 reduced H3K79me2 globally, but it resulted in only a subset of H3K79me2/3 marked loci to be 323 downregulated (Bernt et al., 2011) . In addition, the effects of individual epigenetic modifiers on gene 324 expression were much more specific and limited than predicted by changes in the status of a single 325 histone modification (Lenstra et al., 2011) . On the basis of these studies, we concluded that even 326 though KDM2B influenced H3K79me at a genome-wide level, additional gene-dependent and context-327 dependent mechanisms might be involved in the regulation of gene expression. Recent studies 328 demonstrated the role of histone H4 acetylation as a link between H3K79me and transcriptional 329 activation (Gilan et al., 2016) . This suggested the importance of a particular chromatin context in the 330 regulatory processes mediated by changes in H3K79 methylation. We provided evidence that KDM2B 331 induced the recruitment of SIRT1 to target gene promoters, leading to H4K16 deacetylation and 332 chromatin silencing. This is consistent with an earlier report that CBX8 is a binding partner of SIRT1, 333 and that they cooperatively mediate transcriptional repression (Lee et al., 2013) . 334
To rule out the hypothesis that KDM2B-mediated repression in our study was derived from 335 demethylation of two previously known substrates of KDM2B, H3K4 and H3K36, we overexpressed 336 K4/36R double mutant histone H3 that is not subjected to methylation or demethylation. Transient 337 overexpression of KDM2B following selection of H3 K4/36R-overexpressing stable cells enabled us to 338 rule out repressive effects of K4 and K36 demethylations as the explanation and enabled us to 339 propose an independent mechanism via a new target residue, K79. The wide histone substrate 340 repertoire for KDM2B demethylase activity, which includes H3K36, H3K4, and H3K79, is interesting 341 and suggests the possibility that KDM2B may also have non-histone protein substrates. In addition, 342 considering the identification of new H3K79 HMTases other than DOT1L, it is reasonable to speculate 343 that there may be other H3K79 demethylases besides KDM2B yet to be identified. 344
Given that the H3K36 demethylase activity of KDM2B was not necessary for its variant PRC1-345 mediated H2AK119ub1 and transcriptional repression, we proceeded to determine whether 346
H2AK119ub1 was required to enable the H3K79 demethylase activity of KDM2B in the variant PRC1 347 complex. To test this, we used PRT4165, a potent inhibitor of PRC1-mediated histone H2A 348 ubiquitylation. H2AK119ub levels decreased in the presence of PRT4165, but H3K79me3 349 demethylation catalyzed by KDM2B was not altered, suggesting that the H3K79 demethylase activity 350 of KDM2B was independent of PRC1-mediated H2AK119ub1 (data not shown). Via the demethylation 351 of H3K79, however, KDM2B could possibly play a role in ensuring that genes associated with 352
H2AK119ub1 by PRC1 are also tri-methylated on H3K27 by PRC2 (Yuan et al., 2011) . 353
In summary, we provide in vitro and in vivo evidence for the possible role of KDM2B as an 354
H3K79me2/3 demethylase and as a co-repressor that regulates gene transcription through SIRT1-355 mediated chromatin silencing. Our model suggests that dynamic reversible regulation of histone 356 methylation is indeed applied to H3K79 methylation. This model supports the existence of H3K79 357 demethylation by KDM2B and its role in transcriptional regulation ( Figure 6E) . 
In-gel protein digestion and liquid chromatography tandem-mass spectrometry (LC-MS/MS) 395
Mass spectrometry and proteomic analyses were carried out at the Korea Basic Science Institute. Finnigan LCQ ion trap mass spectrometer. Three extractions were performed to recover all tryptic 407 peptides from the gel slices. Recovered peptides were concentrated by drying the combined extracts 408 in a vacuum centrifuge. Concentrated peptides were mixed with 20 μL of 0.1% formic acid in 3% 409 acetonitrile. Nano LC of the tryptic peptides was performed using the Waters Nano LC system, 410 equipped with a Waters C18 nano column (75 μm × 15 cm, nanoAcquity UPLC column). Binary 411 solvent A1 contained 0.1% formic acid in water, and binary solvent B1 contained 0.1% formic acid in 412 acetonitrile. Samples (5 μL) were loaded onto the column, and peptides were subsequently eluted 413 with a binary solvent B1 gradient (2-40%, 30 min, 0.4 μL/min). The lock mass, [Glu1] fibrinopeptide at 414 400 fmol/μL, was delivered from the auxiliary pump of the Nano LC system at 0.3 μL/min to the 415 reference sprayer of the NanoLockSpray source. 
Histone acid extraction and nucleosome extraction 437
To extract histones, cell pellets were resuspended in PBS with 0.5% Triton X-100 and protease 438 inhibitors, and the tubes were subsequently incubated at 4C for 30 min to lyse the cells. The lysates 439 were centrifuged at 4C for 10 min at 10,000  g, and the pellets were resuspended in 0.4 N H2SO4. 440
The samples were centrifuged at 4C for 10 min at 16,000  g. The pellets were again resuspended in 441 100% trichloroacetic acid (TCA) and centrifuged at 4C for 10 min at 16,000  g. The histone-442 containing pellets were collected and eluted in distilled water. To extract nucleosomes, cell pellets 443 were resuspended in RSB buffer (10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.5% NP-40, 1 444 mM DTT, and 1 mM PMSF), and the tubes were subsequently incubated at 4C for 30 min to lyse the 445 cells. The lysates were centrifuged at 4C for 5 min at 4,000 rpm, and the pellets were resuspended in 446 RSB buffer. The samples were sonicated and centrifuged at 4C for 5 min at 4,000 rpm. The pellets 447
were washed four times with RSB buffer and eluted in the same buffer. 50% for 75 min, and 95% for 1 min. Then, 95% mobile phase B was maintained for 13 min before 479 decreasing to 5% for another 1 min. The column was re-equilibrated with 5% mobile phase B for 10 480 min before the next run. The voltage applied to produce the electrospray was 2.2 kV. During the 481 chromatographic separation, the LTQ Orbitrap Elite was operated in data-dependent mode. MS data 482 were acquired using the following parameters: full scans were acquired in the Orbitrap at a resolution 15 μg core histones from calf thymus (Sigma-Aldrich), and GST-DOT1L, GST-MMSET, or GST-505 SMYD3, respectively. 14 C-labeled histones were subjected to histone demethylase assay using either 506 purified GST or GST-KDM2B1-734. The histones were transferred onto p81 filter paper (Upstate) and 507 washed three times with 95% ethanol for 5 min at room temperature. The filters were allowed to air 508 dry, and 2 mL of Ultima Gold (Perkin Elmer) was added afterwards. 14 C-SAM was then quantified 509 using a scintillation counter. 510 511
Luciferase assay 512
Luciferase assays were conducted using the HOXA7, MEIS1, simian virus 40 (SV40), and thymidine 513 kinase (TK) promoter reporter systems. 293T cells were co-transfected with the corresponding 514 promoter reporter constructs and the indicated DNA constructs, using polyethylenimine (PEI). Cells 515 20 were harvested after 48 h and assayed for luciferase activity using a luciferase assay system 516 (Promega). Each value is expressed as the mean of five replicates of a single assay. All experiments 517 were performed at least three times. 518 519 Chromatin immunoprecipitation (ChIP)-quantitative polymerase chain reaction (qPCR) and 520
ChIP sequencing (ChIP-Seq) Analyses 521
Formaldehyde (1%) was added to the medium for 10 min at room temperature, followed by the 522 addition of 125 mM glycine for 5 min at room temperature. Adherent cells were scraped from dishes 523 into 1 mL PBS. The scraped cells were centrifuged, and the resulting pellets were washed once with 524 PBS. The pellets were resuspended in sodium dodecyl sulfate (SDS) lysis buffer (1% SDS, 10 mM 525 EDTA, and 50 mM Tris-HCl, pH 8.1). The cell lysates were sonicated, diluted with five volumes of 526 dilution buffer (0.01% SDS, 1.2 mM EDTA, 1.1% Triton X-100, 167 mM NaCl, and 16.7 mM Tris-HCl, 527 pH 8.1), and incubated overnight with indicated antibodies (1 μg antibody for each IP reaction). The 528 next day, protein A/G-Agarose beads (GenDEPOT) were added to the reaction, incubated for 2 h, and 529 To analyze promoter regions of HOXA7, MEIS1, ALX1, and GATA4, and 5′ ends of PDE3B, primer 543 sets indicated in Table S1 were used. The primer concentration used for qPCR (Bio-Rad) was 0.2 544 μM/10 μL. The thermal cycler conditions were as follows: 15 min of holding at 95C, followed by 39 545 cycles at 94C for 15 s, 56C for 30 s, and 72C for 30 s. residues critical for binding to H3K79. Iron co-factor and H3K79 residues in the catalytic pocket are 791
shown. (C) Radioactive assay using core histones. H3K79 residues were 14 C-labeled by GST-DOT1L 792 through histone methyltransferase assay and the histones were used in histone demethylase assays 793 with GST-KDM2B. Remaining radioactivity levels from histones were measured by scintillation 794 counting to assess demethylase activity. All error bars indicate standard error of mean (SEM) for at 795 least triplicated experiments. (D) Radioactive assays using core histones. H3K79, H3K36, and H3K4 796 residues were 14 C-labeled by DOT1L, MMSET, and SMYD3, respectively. 14 C-labeled histones were 797 used in histone demethylase assays with KDM2B. Remaining radioactivity levels from histones were 798 measured by scintillation counting to assess demethylase activity. 
